(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 2 more ... CTD PMID:18579281 1,2-dimethylhydrazine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FKBP5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of FKBP5 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of FKBP5 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO FKBP5 (Homo sapiens) 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO Fkbp5 (Mus musculus) 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA and Estradiol inhibits the reaction [[Bucladesine co-treated with fulvestrant] results in decreased expression of FKBP5 mRNA] CTD PMID:19693291 and PMID:26427651 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of FKBP5 mRNA] CTD PMID:21440447 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO FKBP5 (Homo sapiens) 6480464 Metribolone results in increased expression of FKBP5 mRNA and Metribolone results in increased expression of FKBP5 protein CTD PMID:16751804 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO FKBP5 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of FKBP5 mRNA CTD PMID:18007998 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FKBP5 mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBP5 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FKBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FKBP5 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FKBP5 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of FKBP5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of FKBP5 mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Fkbp5 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A increases expression ISO Fkbp5 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of FKBP5 mRNA CTD PMID:30496566 3,5,6-trichloro-2-pyridinol multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3,5,6-trichloropyridine-2-one multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FKBP5 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FKBP5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FKBP5 mRNA CTD PMID:28628672 3-phenoxybenzoic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3H-1,2-dithiole-3-thione increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 2-dithiol-3-thione results in increased expression of FKBP5 mRNA CTD PMID:15375163 4,4'-diaminodiphenylmethane increases expression ISO Fkbp5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FKBP5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FKBP5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol S results in increased expression of FKBP5 protein CTD PMID:34186270 5-fluorouracil multiple interactions ISO FKBP5 (Homo sapiens) 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of FKBP5 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of FKBP5 mRNA CTD PMID:31881176 acrylamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Acrylamide results in decreased expression of FKBP5 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO FKBP5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of FKBP5 gene CTD PMID:27153756 alcohol increases expression ISO Fkbp5 (Mus musculus) 401976495 alcohol increases expression of Fkbp5 mRNA and protein in liver RGD alcohol affects expression EXP 401976487 alcohol affects expression of Fkbp5 mRNA in ventral tegmental area and nucleus accumbens and cingulate cortex RGD aldrin decreases expression ISO Fkbp5 (Mus musculus) 6480464 Aldrin results in decreased expression of FKBP5 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO FKBP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of FKBP5 mRNA CTD PMID:15498508 more ... amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FKBP5 mRNA CTD PMID:30779732 amphotericin B decreases expression ISO FKBP5 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of FKBP5 mRNA CTD PMID:28534445 antimycin A increases expression ISO FKBP5 (Homo sapiens) 6480464 Antimycin A results in increased expression of FKBP5 mRNA CTD PMID:33512557 arsane multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic inhibits the reaction [Progesterone results in increased expression of FKBP5 mRNA] CTD PMID:33047385 arsane decreases expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic results in decreased expression of FKBP5 mRNA CTD PMID:33047385 arsenic atom multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic inhibits the reaction [Progesterone results in increased expression of FKBP5 mRNA] CTD PMID:33047385 arsenic atom decreases expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic results in decreased expression of FKBP5 mRNA CTD PMID:33047385 arsenous acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FKBP5 protein] CTD PMID:26598702 arsenous acid affects expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of FKBP5 mRNA CTD PMID:25873331 atazanavir sulfate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO FKBP5 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of FKBP5 mRNA CTD PMID:32152650 atenolol decreases expression ISO FKBP5 (Homo sapiens) 6480464 Atenolol results in decreased expression of FKBP5 mRNA CTD PMID:19915711 Aurin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 aurin inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] and aurin inhibits the reaction [NR3C1 protein results in increased expression of FKBP5 mRNA] CTD PMID:19255438 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 benzene increases expression ISO FKBP5 (Homo sapiens) 6480464 Benzene results in increased expression of FKBP5 protein CTD PMID:15036117 benzo[a]pyrene decreases expression ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FKBP5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO FKBP5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of FKBP5 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO FKBP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FKBP5 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of FKBP5 exon and Benzo(a)pyrene results in increased methylation of FKBP5 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FKBP5 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO FKBP5 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FKBP5 mRNA CTD PMID:18164116 bicalutamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 bicalutamide results in decreased expression of FKBP5 mRNA CTD PMID:28500234 bicalutamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA CTD PMID:28500234 bis(2-chloroethyl) sulfide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Mustard Gas results in increased alkylation of Dexamethasone] which results in increased expression of FKBP5 mRNA CTD PMID:31515601 bis(2-ethylhexyl) phthalate increases expression ISO Fkbp5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of FKBP5 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate increases expression ISO FKBP5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of FKBP5 protein CTD PMID:31163220 bisphenol A decreases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of FKBP5 mRNA and bisphenol A results in decreased expression of FKBP5 protein CTD PMID:18007998 more ... bisphenol A increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol A results in increased expression of FKBP5 protein CTD PMID:37567409 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FKBP5 intron CTD PMID:26427651 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FKBP5 mRNA and bisphenol A results in decreased expression of FKBP5 protein CTD PMID:26427651 and PMID:34947998 bisphenol A multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [bisphenol A co-treated with Bucladesine] results in increased methylation of FKBP5 intron more ... CTD PMID:26427651 and PMID:32518293 bisphenol A increases expression ISO Fkbp5 (Mus musculus) 6480464 bisphenol A results in increased expression of FKBP5 mRNA CTD PMID:25594700 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FKBP5 mRNA CTD PMID:24988533 more ... Bisphenol B increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol B results in increased expression of FKBP5 protein CTD PMID:34186270 bisphenol F increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol F results in increased expression of FKBP5 protein CTD PMID:34186270 bortezomib decreases expression ISO FKBP5 (Homo sapiens) 6480464 Bortezomib results in decreased expression of FKBP5 mRNA CTD PMID:20977926 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FKBP5 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [bisphenol A co-treated with Bucladesine] results in increased methylation of FKBP5 intron more ... CTD PMID:26427651 buta-1,3-diene increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of FKBP5 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FKBP5 mRNA CTD PMID:29432896 Butylbenzyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of FKBP5 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FKBP5 mRNA CTD PMID:37325564 cadmium dichloride decreases expression ISO FKBP5 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of FKBP5 mRNA CTD PMID:18560533 cadmium dichloride multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FKBP5 mRNA CTD PMID:37325564 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FKBP5 mRNA CTD PMID:25993096 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of FKBP5 mRNA CTD PMID:22110744 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of FKBP5 promoter CTD PMID:22457795 caffeine increases phosphorylation ISO FKBP5 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of FKBP5 protein CTD PMID:35688186 calcitriol increases expression ISO FKBP5 (Homo sapiens) 6480464 Calcitriol results in increased expression of FKBP5 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FKBP5 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO Fkbp5 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of FKBP5 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Fkbp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 carmustine increases expression EXP 6480464 Carmustine results in increased expression of FKBP5 mRNA CTD PMID:16005536 CCCP multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein] promotes the reaction [FKBP5 protein binds to PINK1 protein] CTD PMID:30734931 CGP 52608 multiple interactions ISO FKBP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FKBP5 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 chlordecone increases expression ISO Fkbp5 (Mus musculus) 6480464 Chlordecone results in increased expression of FKBP5 mRNA CTD PMID:33711761 chloroethene decreases expression ISO Fkbp5 (Mus musculus) 6480464 Vinyl Chloride results in decreased expression of FKBP5 mRNA CTD PMID:18579281 chloroprene increases expression ISO Fkbp5 (Mus musculus) 6480464 Chloroprene results in increased expression of FKBP5 mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of FKBP5 mRNA CTD PMID:23125180 chlorpromazine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Chlorpromazine inhibits the reaction [Lipopolysaccharides results in decreased expression of FKBP5 protein] CTD PMID:21034739 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 ciclopirox multiple interactions ISO FKBP5 (Homo sapiens) 6480464 ciclopirox inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:19255438 ciguatoxin CTX1B affects expression ISO Fkbp5 (Mus musculus) 6480464 Ciguatoxins affects the expression of FKBP5 mRNA CTD PMID:18353800 clofibrate decreases expression ISO Fkbp5 (Mus musculus) 6480464 Clofibrate results in decreased expression of FKBP5 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO FKBP5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of FKBP5 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FKBP5 mRNA CTD PMID:24386269 cocaine increases expression EXP 401976486 cocaine increases expression of Fkbp5 mRNA in bed nucleus of the stria terminalis and central amygdala and paraventricular nucleus RGD colforsin daropate hydrochloride multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:19255438 copper atom multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FKBP5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FKBP5 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO FKBP5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of FKBP5 mRNA CTD PMID:19549813 copper(II) sulfate decreases expression ISO Fkbp5 (Mus musculus) 6480464 Copper Sulfate results in decreased expression of FKBP5 mRNA CTD PMID:18579281 corticosterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] CTD PMID:31344373 corticosterone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Corticosterone results in decreased expression of FKBP5 mRNA CTD PMID:31344373 cortisol increases expression ISO FKBP5 (Homo sapiens) 6480464 Hydrocortisone results in increased expression of FKBP5 mRNA CTD PMID:21267416 coumestrol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA CTD PMID:19167446 coumestrol increases expression ISO FKBP5 (Homo sapiens) 6480464 Coumestrol results in increased expression of FKBP5 mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FKBP5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO FKBP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FKBP5 mRNA CTD PMID:20106945 and PMID:32152650 cyclosporin A multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 dapsone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of FKBP5 mRNA] CTD PMID:21440447 DDE multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 deoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 dexamethasone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] more ... CTD PMID:17690134 more ... dexamethasone increases expression ISO FKBP5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of FKBP5 mRNA and Dexamethasone results in increased expression of FKBP5 protein CTD PMID:12732289 more ... dexamethasone increases expression ISO Fkbp5 (Mus musculus) 6480464 Dexamethasone results in increased expression of FKBP5 mRNA CTD PMID:22733784 more ... dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:20032058 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FKBP5 mRNA CTD PMID:20032058 more ... dexamethasone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Bucladesine co-treated with Dexamethasone] results in increased expression of FKBP5 mRNA more ... CTD PMID:16054899 more ... diarsenic trioxide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FKBP5 protein] CTD PMID:26598702 diarsenic trioxide affects expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of FKBP5 mRNA CTD PMID:25873331 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FKBP5 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FKBP5 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of FKBP5 mRNA CTD PMID:28962523 diethyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 Diisodecyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 dimethylarsinic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 dioxygen multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP5 mRNA CTD PMID:30529165 diquat increases expression ISO Fkbp5 (Mus musculus) 6480464 Diquat results in increased expression of FKBP5 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 FKBP5 protein affects the reaction [Doxorubicin results in increased degradation of and results in decreased expression of NFKBIA protein] CTD PMID:15571967 doxorubicin decreases expression ISO FKBP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of FKBP5 mRNA CTD PMID:29803840 doxorubicin increases expression ISO Fkbp5 (Mus musculus) 6480464 Doxorubicin results in increased expression of FKBP5 mRNA CTD PMID:25896364 edaravone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] CTD PMID:31344373 entinostat increases expression ISO FKBP5 (Homo sapiens) 6480464 entinostat results in increased expression of FKBP5 mRNA CTD PMID:26272509 and PMID:27188386 entinostat multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP5 mRNA CTD PMID:27188386 enzalutamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [enzalutamide co-treated with NVP-BHG712] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32184358 enzalutamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 enzalutamide results in decreased expression of FKBP5 mRNA CTD PMID:32184358 enzyme inhibitor multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP5 protein CTD PMID:23301498 epoxiconazole affects expression ISO Fkbp5 (Mus musculus) 6480464 epoxiconazole affects the expression of FKBP5 mRNA CTD PMID:35436446 ethanol affects expression ISO Fkbp5 (Mus musculus) 6480464 Ethanol affects the expression of FKBP5 mRNA CTD PMID:30319688 folic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FKBP5 mRNA CTD PMID:22206623 folpet increases expression ISO Fkbp5 (Mus musculus) 6480464 folpet results in increased expression of FKBP5 mRNA CTD PMID:31558096 FR900359 increases phosphorylation ISO FKBP5 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of FKBP5 protein CTD PMID:37730182 fulvestrant multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Bucladesine co-treated with fulvestrant] results in decreased expression of FKBP5 mRNA more ... CTD PMID:26427651 furan increases expression EXP 6480464 furan results in increased expression of FKBP5 mRNA CTD PMID:26194646 Galiellalactone decreases expression ISO FKBP5 (Homo sapiens) 6480464 galiellalactone results in decreased expression of FKBP5 mRNA CTD PMID:30254184 genistein decreases expression EXP 6480464 Genistein results in decreased expression of FKBP5 mRNA CTD PMID:23160963 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FKBP5 mRNA CTD PMID:24136188 glycidol increases expression EXP 6480464 glycidol results in increased expression of FKBP5 mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glyphosate decreases expression ISO Fkbp5 (Mus musculus) 6480464 Glyphosate results in decreased expression of FKBP5 protein CTD PMID:37208198 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 graphene oxide increases expression ISO Fkbp5 (Mus musculus) 6480464 graphene oxide results in increased expression of FKBP5 mRNA CTD PMID:33227293 hexadecanoic acid decreases phosphorylation ISO FKBP5 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of FKBP5 protein CTD PMID:28073184 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 indometacin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FKBP5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FKBP5 mRNA CTD PMID:28628672 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of FKBP5 mRNA CTD PMID:20097248 isoprenaline increases expression ISO Fkbp5 (Mus musculus) 6480464 Isoproterenol results in increased expression of FKBP5 mRNA CTD PMID:20003209 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of FKBP5 mRNA CTD PMID:22641619 lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of FKBP5 gene CTD PMID:29571894 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of FKBP5 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:21034739 and PMID:35811015 lipopolysaccharide increases expression ISO FKBP5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of FKBP5 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of FKBP5 protein CTD PMID:21034739 maneb multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of FKBP5 mRNA CTD PMID:18386188 medroxyprogesterone acetate increases expression ISO FKBP5 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of FKBP5 mRNA CTD PMID:19146866 and PMID:20843944 mercury dibromide decreases expression ISO FKBP5 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of FKBP5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FKBP5 mRNA CTD PMID:30467583 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of FKBP5 mRNA CTD PMID:16005536 methylarsonic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 methylseleninic acid affects expression ISO FKBP5 (Homo sapiens) 6480464 methylselenic acid affects the expression of FKBP5 mRNA CTD PMID:14617803 mifepristone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:17690134 mono(2-ethylhexyl) phthalate decreases expression ISO Fkbp5 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP5 mRNA CTD PMID:22401849 N-acetyl-L-cysteine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA] CTD PMID:18829485 N-methyl-4-phenylpyridinium decreases expression ISO Fkbp5 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FKBP5 protein CTD PMID:26558463 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FKBP5 mRNA CTD PMID:18164116 naphthalene increases expression ISO Fkbp5 (Mus musculus) 6480464 naphthalene results in increased expression of FKBP5 mRNA CTD PMID:18978301 nefazodone decreases expression ISO FKBP5 (Homo sapiens) 6480464 nefazodone results in decreased expression of FKBP5 mRNA CTD PMID:32152650 nefazodone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of FKBP5 mRNA and Nevirapine results in increased expression of FKBP5 mRNA CTD PMID:23947594 niclosamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Niclosamide results in decreased expression of FKBP5 mRNA CTD PMID:28500234 niclosamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA CTD PMID:28500234 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of FKBP5 mRNA CTD PMID:30449730 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FKBP5 mRNA CTD PMID:25729387 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of FKBP5 mRNA CTD PMID:23439660 ozone increases expression ISO Fkbp5 (Mus musculus) 6480464 Ozone results in increased expression of FKBP5 mRNA CTD PMID:17460151 and PMID:19555225 ozone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FKBP5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FKBP5 mRNA CTD PMID:34911549 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FKBP5 mRNA CTD PMID:37047376 ozone increases expression EXP 6480464 Ozone results in increased expression of FKBP5 mRNA CTD PMID:28623178 more ... paracetamol affects expression ISO Fkbp5 (Mus musculus) 6480464 Acetaminophen affects the expression of FKBP5 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FKBP5 mRNA CTD PMID:32479839 paracetamol decreases expression ISO FKBP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FKBP5 mRNA CTD PMID:29067470 paraquat increases expression ISO Fkbp5 (Mus musculus) 6480464 Paraquat results in increased expression of FKBP5 mRNA CTD PMID:12595580 and PMID:21463325 paraquat multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of FKBP5 mRNA CTD PMID:18386188 paraquat affects expression EXP 6480464 Paraquat affects the expression of FKBP5 mRNA CTD PMID:16854511 parathion increases expression ISO Fkbp5 (Mus musculus) 6480464 Parathion results in increased expression of FKBP5 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO Fkbp5 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of FKBP5 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO FKBP5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of FKBP5 mRNA CTD PMID:27153767 perfluorooctanoic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of FKBP5 mRNA CTD PMID:33325755 phenobarbital increases expression ISO Fkbp5 (Mus musculus) 6480464 Phenobarbital results in increased expression of FKBP5 mRNA CTD PMID:19270015 phenobarbital affects expression ISO FKBP5 (Homo sapiens) 6480464 Phenobarbital affects the expression of FKBP5 mRNA CTD PMID:19159669 phenylmercury acetate decreases expression ISO FKBP5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of FKBP5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA CTD PMID:27188386 phlorizin decreases expression ISO Fkbp5 (Mus musculus) 6480464 Phlorhizin results in decreased expression of FKBP5 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA] CTD PMID:20858459 phorbol 13-acetate 12-myristate increases expression ISO FKBP5 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA CTD PMID:20858459 phytoestrogen multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of FKBP5 mRNA CTD PMID:33325755 picoxystrobin increases expression ISO FKBP5 (Homo sapiens) 6480464 picoxystrobin results in increased expression of FKBP5 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of FKBP5 mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO Fkbp5 (Mus musculus) 6480464 pirinixic acid results in increased expression of FKBP5 mRNA CTD PMID:18301758 more ... pregnenolone 16alpha-carbonitrile increases expression ISO Fkbp5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of FKBP5 mRNA CTD PMID:28903501 progesterone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA more ... CTD PMID:17404688 more ... progesterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA CTD PMID:19693291 progesterone increases expression ISO FKBP5 (Homo sapiens) 6480464 Progesterone results in increased expression of FKBP5 mRNA CTD PMID:17404688 more ... quinomethionate affects expression ISO FKBP5 (Homo sapiens) 6480464 quinomethionate affects the expression of FKBP5 mRNA CTD PMID:15387888 raloxifene increases expression ISO FKBP5 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of FKBP5 mRNA CTD PMID:22217510 resveratrol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA CTD PMID:19167446 resveratrol increases expression ISO Fkbp5 (Mus musculus) 6480464 resveratrol results in increased expression of FKBP5 protein CTD PMID:25505154 rotenone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Rotenone results in decreased expression of FKBP5 mRNA CTD PMID:23186747 rotenone increases expression EXP 6480464 Rotenone results in increased expression of FKBP5 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FKBP5 mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of FKBP5 protein CTD PMID:23736079 SB 431542 multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 silicon dioxide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of FKBP5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Fkbp5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of FKBP5 mRNA CTD PMID:23221170 and PMID:29341224 sodium arsenite increases expression ISO FKBP5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FKBP5 mRNA CTD PMID:28595984 and PMID:34032870 sodium arsenite increases expression ISO Fkbp5 (Mus musculus) 6480464 sodium arsenite results in increased expression of FKBP5 mRNA CTD PMID:17682005 sodium arsenite multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of FKBP5 mRNA and [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 and PMID:25873331 sodium dichromate decreases expression ISO Fkbp5 (Mus musculus) 6480464 sodium bichromate results in decreased expression of FKBP5 mRNA CTD PMID:22155349 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FKBP5 mRNA CTD PMID:22561333 and PMID:25993096 sodium fluoride decreases expression ISO Fkbp5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of FKBP5 protein CTD PMID:28918527 tacrolimus hydrate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 tamibarotene decreases expression ISO FKBP5 (Homo sapiens) 6480464 tamibarotene results in decreased expression of FKBP5 mRNA CTD PMID:15498508 tamoxifen affects expression ISO Fkbp5 (Mus musculus) 6480464 Tamoxifen affects the expression of FKBP5 mRNA CTD PMID:20937368 testosterone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FKBP5 mRNA CTD PMID:21592394 testosterone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of FKBP5 mRNA CTD PMID:33848595 testosterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO Fkbp5 (Mus musculus) 6480464 Testosterone results in increased expression of FKBP5 mRNA CTD PMID:19693291 and PMID:20403060 testosterone increases expression ISO FKBP5 (Homo sapiens) 6480464 Testosterone results in increased expression of FKBP5 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:20032058 testosterone enanthate affects expression ISO FKBP5 (Homo sapiens) 6480464 testosterone enanthate affects the expression of FKBP5 mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of FKBP5 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FKBP5 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Fkbp5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FKBP5 mRNA CTD PMID:31919559 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 tibolone increases expression ISO FKBP5 (Homo sapiens) 6480464 tibolone results in increased expression of FKBP5 mRNA CTD PMID:22217510 tioguanine increases expression EXP 6480464 Thioguanine results in increased expression of FKBP5 mRNA CTD PMID:16005536 titanium dioxide decreases expression ISO Fkbp5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of FKBP5 mRNA CTD PMID:19464567 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FKBP5 mRNA CTD PMID:30012374 titanium dioxide increases expression ISO Fkbp5 (Mus musculus) 6480464 titanium dioxide results in increased expression of FKBP5 mRNA CTD PMID:27760801 and PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FKBP5 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FKBP5 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of FKBP5 gene CTD PMID:27618143 triclosan decreases expression ISO FKBP5 (Homo sapiens) 6480464 Triclosan results in decreased expression of FKBP5 mRNA CTD PMID:30510588 Triptolide decreases expression ISO Fkbp5 (Mus musculus) 6480464 triptolide results in decreased expression of FKBP5 mRNA CTD PMID:32835833 triptonide decreases expression ISO Fkbp5 (Mus musculus) 6480464 triptonide results in decreased expression of FKBP5 mRNA CTD PMID:33045310 urethane increases expression ISO FKBP5 (Homo sapiens) 6480464 Urethane results in increased expression of FKBP5 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of FKBP5 mRNA CTD PMID:24136188 valproic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of FKBP5 mRNA CTD PMID:17292431 valproic acid affects expression ISO FKBP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of FKBP5 mRNA CTD PMID:25979313 valproic acid increases expression ISO FKBP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FKBP5 mRNA CTD PMID:23179753 zearalenone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Zearalenone results in decreased expression of FKBP5 mRNA CTD PMID:24412631